The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients.

Cancer Res Commun · 2026 · PMC12869149 · PMID 41642747

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

A slight trend toward fewer related AEs but a marginal increase in SAEs was noted in the 6-hour treatments; however, the limited sample size prevents definitive conclusions.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.